CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiation Oncology Journal. 2022;40(2):111-119.   Published online 2022 May 20    DOI: https://doi.org/10.3857/roj.2021.01060

Excel Download

Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Radiation Oncology Journal. 2022;40(2):111-119   Crossref logo
Link1 Link2 Link3

Elevated Absolute Monocyte Count, Absolute Neutrophil Count, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2015;93(3):E157   Crossref logo
Link1 Link2

Pre-treatment Neutrophil to Lymphocyte ratio (NLR) is a Prognostic Biomarker for Overall Survival in Localized Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):e714   Crossref logo
Link1 Link2

Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
Frontiers in Oncology. 2018;8:   Crossref logo
Link1

Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker
International Journal of Radiation Oncology*Biology*Physics. 2016;96(2):E153   Crossref logo
Link1 Link2

Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point
Clinical and Translational Radiation Oncology. 2021;28:133-140   Crossref logo
Link1 Link2

Post-treatment neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic marker in patients with localized pancreatic cancer treated with neoadjuvant therapy
Journal of the American College of Surgeons. 2015;221(4):e21   Crossref logo
Link1 Link2 Link3

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on Metastases
International Journal of Radiation Oncology*Biology*Physics. 2019;105(1):E524   Crossref logo
Link1 Link2

What is the Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients Treated With Selective Internal Radiation Therapy?
International Journal of Radiation Oncology*Biology*Physics. 2015;93(3):E137   Crossref logo
Link1 Link2

Can the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predict Survival or Local Control in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? A Systematic Review
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):e706-e707   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.